Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans

E Jaensson, H Uronen-Hansson, O Pabst… - The Journal of …, 2008 - rupress.org
E Jaensson, H Uronen-Hansson, O Pabst, B Eksteen, J Tian, JL Coombes, PL Berg…
The Journal of experimental medicine, 2008rupress.org
A functionally distinct subset of CD103+ dendritic cells (DCs) has recently been identified in
murine mesenteric lymph nodes (MLN) that induces enhanced FoxP3+ T cell differentiation,
retinoic acid receptor signaling, and gut-homing receptor (CCR9 and α4β7) expression in
responding T cells. We show that this function is specific to small intestinal lamina propria (SI-
LP) and MLN CD103+ DCs. CD103+ SI-LP DCs appeared to derive from circulating DC
precursors that continually seed the SI-LP. BrdU pulse-chase experiments suggested that …
A functionally distinct subset of CD103+ dendritic cells (DCs) has recently been identified in murine mesenteric lymph nodes (MLN) that induces enhanced FoxP3+ T cell differentiation, retinoic acid receptor signaling, and gut-homing receptor (CCR9 and α4β7) expression in responding T cells. We show that this function is specific to small intestinal lamina propria (SI-LP) and MLN CD103+ DCs. CD103+ SI-LP DCs appeared to derive from circulating DC precursors that continually seed the SI-LP. BrdU pulse-chase experiments suggested that most CD103+ DCs do not derive from a CD103 SI-LP DC intermediate. The majority of CD103+ MLN DCs appear to represent a tissue-derived migratory population that plays a central role in presenting orally derived soluble antigen to CD8+ and CD4+ T cells. In contrast, most CD103 MLN DCs appear to derive from blood precursors, and these cells could proliferate within the MLN and present systemic soluble antigen. Critically, CD103+ DCs with similar phenotype and functional properties were present in human MLN, and their selective ability to induce CCR9 was maintained by CD103+ MLN DCs isolated from SB Crohn's patients. Thus, small intestinal CD103+ DCs represent a potential novel target for regulating human intestinal inflammatory responses.
rupress.org